Given that sympathoadrenal progenitor cells (SAPs) are the likely cells of origin for neuroblastoma, and that MYCN plays a key role in neuroblastoma development and prognosis, it is important to understand the effects of MYCN expression on SAPs. This evidence concerns the gene MYCN and neuroblastoma.